Type 1 Diabetes Defense Foundation Statement on the Nomination of Alex Azar to Lead HHS

Type 1 Diabetes Defense Foundation Statement on the Nomination of Alex Azar to Lead HHS

The Type 1 Diabetes Defense Foundation is deeply concerned by the nomination of Alex Azar to lead the Department of Health and Human Services. Azar once advocated for healthcare consumer empowerment and price transparency. But during his 2012–17 tenure as president of Lilly USA, LLC, he evolved into an aggressive enabler of the opaque drug pricing system that as former Deputy Secretary of HHS he had once pledged to reform.

Read More